ANGO logo

AngioDynamics (ANGO) Shareholders Equity

Annual Shareholders Equity

$205.59 M
-$172.71 M-45.65%

May 31, 2024


Summary


Performance

ANGO Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANGObalance sheetmetrics:

Quarterly Shareholders Equity

$186.77 M
-$9.81 M-4.99%

November 30, 2024


Summary


Performance

ANGO Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANGObalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

ANGO Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-45.6%-9.2%
3 y3 years-53.2%-56.8%
5 y5 years-66.6%-69.6%

ANGO Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-53.2%at low-56.8%at low
5 y5-year-66.6%at low-69.6%at low
alltimeall time-66.6%>+9999.0%-69.6%>+9999.0%

AngioDynamics Shareholders Equity History

DateAnnualQuarterly
Nov 2024
-
$186.77 M(-5.0%)
Aug 2024
-
$196.58 M(-4.4%)
May 2024
$205.59 M(-45.7%)
$205.59 M(-6.0%)
Feb 2024
-
$218.70 M(-45.5%)
Nov 2023
-
$401.23 M(-6.2%)
Aug 2023
-
$427.80 M(+13.1%)
May 2023
$378.30 M(-10.9%)
$378.30 M(-4.9%)
Feb 2023
-
$397.65 M(-2.5%)
Nov 2022
-
$407.96 M(-1.5%)
Aug 2022
-
$414.04 M(-2.5%)
May 2022
-
$424.49 M(-1.2%)
May 2022
$424.49 M(-3.4%)
-
Feb 2022
-
$429.69 M(-0.6%)
Nov 2021
-
$432.37 M(-0.8%)
Aug 2021
-
$435.95 M(-0.8%)
May 2021
$439.46 M(-3.4%)
$439.46 M(-3.4%)
Feb 2021
-
$454.94 M(+0.1%)
Nov 2020
-
$454.34 M(-0.2%)
Aug 2020
-
$455.05 M(+0.0%)
May 2020
$454.87 M(-26.0%)
$454.87 M(-25.5%)
Feb 2020
-
$610.48 M(-0.5%)
Nov 2019
-
$613.81 M(-0.0%)
Aug 2019
-
$614.07 M(-0.1%)
May 2019
$614.82 M(+13.3%)
$614.82 M(+11.0%)
Feb 2019
-
$554.08 M(+0.8%)
Nov 2018
-
$549.56 M(+0.9%)
Aug 2018
-
$544.89 M(+0.4%)
May 2018
$542.60 M(+5.4%)
$542.60 M(+0.8%)
Feb 2018
-
$538.33 M(+3.3%)
Nov 2017
-
$521.22 M(+0.6%)
Aug 2017
-
$517.88 M(+0.6%)
May 2017
$515.03 M(+1.5%)
$515.03 M(-3.1%)
Feb 2017
-
$531.75 M(+1.6%)
Nov 2016
-
$523.35 M(+2.1%)
Aug 2016
-
$512.72 M(+1.1%)
May 2016
$507.23 M(-6.9%)
$507.23 M(-7.9%)
Feb 2016
-
$550.75 M(+0.6%)
Nov 2015
-
$547.64 M(+0.1%)
Aug 2015
-
$547.12 M(+0.4%)
May 2015
$545.10 M(+1.5%)
$545.10 M(+0.2%)
Feb 2015
-
$543.76 M(+0.0%)
Nov 2014
-
$543.57 M(+0.7%)
Aug 2014
-
$539.68 M(+0.5%)
DateAnnualQuarterly
May 2014
$536.84 M(+2.0%)
$536.84 M(-0.2%)
Feb 2014
-
$537.69 M(+1.5%)
Nov 2013
-
$529.73 M(+0.2%)
Aug 2013
-
$528.45 M(+0.4%)
May 2013
$526.10 M(+0.5%)
$526.10 M(-0.2%)
Feb 2013
-
$527.36 M(+0.1%)
Nov 2012
-
$526.69 M(+0.5%)
Aug 2012
-
$523.88 M(+0.1%)
May 2012
$523.52 M(+29.1%)
$523.52 M(+27.3%)
Feb 2012
-
$411.36 M(+0.1%)
Nov 2011
-
$410.85 M(+0.4%)
Aug 2011
-
$409.30 M(+0.9%)
May 2011
$405.64 M(+3.7%)
$405.64 M(+0.0%)
Feb 2011
-
$405.57 M(+1.5%)
Nov 2010
-
$399.45 M(+1.0%)
Aug 2010
-
$395.44 M(+1.0%)
May 2010
$391.35 M(+5.1%)
$391.35 M(+1.1%)
Feb 2010
-
$386.91 M(+1.6%)
Nov 2009
-
$380.74 M(+1.3%)
Aug 2009
-
$376.03 M(+1.0%)
May 2009
$372.19 M(+4.6%)
$372.19 M(+1.2%)
Feb 2009
-
$367.88 M(+1.2%)
Nov 2008
-
$363.54 M(+1.0%)
Aug 2008
-
$359.95 M(+1.2%)
May 2008
$355.71 M(+5.9%)
$355.71 M(+0.6%)
Feb 2008
-
$353.55 M(+2.2%)
Nov 2007
-
$345.95 M(+1.6%)
Aug 2007
-
$340.37 M(+1.3%)
May 2007
$335.96 M(+172.2%)
$335.96 M(+1.4%)
Feb 2007
-
$331.27 M(+152.4%)
Nov 2006
-
$131.27 M(+3.4%)
Aug 2006
-
$127.00 M(+2.9%)
May 2006
$123.44 M(+151.4%)
$123.44 M(+115.3%)
Feb 2006
-
$57.33 M(+5.6%)
Nov 2005
-
$54.29 M(+4.4%)
Aug 2005
-
$52.02 M(+5.9%)
May 2005
$49.11 M(+31.9%)
$49.11 M(+8.6%)
Feb 2005
-
$45.24 M(+8.1%)
Nov 2004
-
$41.86 M(+2.8%)
Aug 2004
-
$40.73 M(+9.4%)
May 2004
$37.23 M(+2402.2%)
$37.23 M(+900.9%)
Feb 2004
-
$3.72 M(+150.0%)
May 2003
$1.49 M(-604.4%)
$1.49 M
May 2002
-$295.00 K
-

FAQ

  • What is AngioDynamics annual stockholders equity?
  • What is the all time high annual shareholders equity for AngioDynamics?
  • What is AngioDynamics annual shareholders equity year-on-year change?
  • What is AngioDynamics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for AngioDynamics?
  • What is AngioDynamics quarterly shareholders equity year-on-year change?

What is AngioDynamics annual stockholders equity?

The current annual shareholders equity of ANGO is $205.59 M

What is the all time high annual shareholders equity for AngioDynamics?

AngioDynamics all-time high annual stockholders equity is $614.82 M

What is AngioDynamics annual shareholders equity year-on-year change?

Over the past year, ANGO annual stockholders equity has changed by -$172.71 M (-45.65%)

What is AngioDynamics quarterly stockholders equity?

The current quarterly shareholders equity of ANGO is $186.77 M

What is the all time high quarterly shareholders equity for AngioDynamics?

AngioDynamics all-time high quarterly stockholders equity is $614.82 M

What is AngioDynamics quarterly shareholders equity year-on-year change?

Over the past year, ANGO quarterly stockholders equity has changed by -$18.82 M (-9.15%)